You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Valneva delivers additional data for COVID-19 booster vaccine

Following a clinical study, Valneva’s COVID-19 booster vaccine candidate, VLA2001, has yielded more data. A subset of participants received VLA2001 following two or three doses of the mRNA COVID-19 vaccine, with or without break-through infection among 25 to 50 participants per group.